ClinicalTrials.gov record

Terminated Early Phase 1 Interventional Accepts healthy volunteers Results available

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

ClinicalTrials.gov ID: NCT05819619

Public ClinicalTrials.gov record NCT05819619. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 12, 2026, 3:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID: NCT05819619
Recruitment status: Terminated
Study type: Interventional
Phase: Early Phase 1
Lead sponsor: Hackensack Meridian Health; Other
Enrollment: 8 participants

Conditions and interventions

Conditions

Interventions

Prophylactic use of ibuprofen and ondansetron post misoprostol administration Drug
Use of ibuprofen and ondansetron at symptom onset post misoprostol administration Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 50 Years
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 19, 2023
Primary completion: Mar 31, 2024
Completion: Apr 10, 2024
Last update posted: Nov 16, 2025

2023 – 2024

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Antonia Oladipo	Hackensack	New Jersey	07601	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT05819619, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Nov 16, 2025 · Synced May 12, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05819619 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →